Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 5/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
| ▸ | PTGIR | P43119 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL424401 | 1.00 | CNR2 (0.33) | CNR2MEN1GAAKMT2ASMN1; SMN2 | |
| SCHEMBL3463067 | 0.92 | PTGIR (0.33) | CNR2MEN1GAAKMT2ASMN1; SMN2 | |
| SCHEMBL6515405 | 0.92 | PTGIR (0.33) | CNR2MEN1GAAKMT2ASMN1; SMN2 | |
| SCHEMBL6411933 | 0.86 | PTGIR (0.34) | CNR2MEN1GAAKMT2ASMN1; SMN2 | |
| SCHEMBL4623301 | 0.86 | PTGIR (0.34) | CNR2MEN1GAAKMT2ASMN1; SMN2 | |
| SCHEMBL4623306 | 0.86 | PTGIR (0.34) | CNR2MEN1GAAKMT2ASMN1; SMN2 | |
| SCHEMBL2356991 | 0.80 | FKBP1A (0.35) | PTGIRKDM4E | |
| SCHEMBL424402 | 0.79 | MEN1 (0.35) | CNR2MEN1GAAKMT2ASMN1; SMN2 | |
| SCHEMBL7995297 | 0.72 | ALDH1A1 (0.34) | MEN1GAAKMT2ASMN1; SMN2KDM4E | |
| SCHEMBL7972362 | 0.72 | ALDH1A1 (0.34) | MEN1GAAKMT2ASMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120021911-A1 | Plant Treatment Compositions and Methods for Their Use | GOWAN CO. (US) | 2012-01-26 | — | — | US | disclosed |
| US-20110230348-A1 | PEHAM Dendrimers for Use in Agriculture | DENDRITIC NANOTECHNOLOGIES, INC. (US) | 2011-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110230348-A1 | PEHAM Dendrimers for Use in Agriculture | MGAM, PGLS, CAT | CNR2 4575/4885MEN1 3815/4885GAA 117/4885 |
| US-20120021911-A1 | Plant Treatment Compositions and Methods for Their Use | ALG1, DDT, ALG3 | CNR2 2954/4885MEN1 2207/4885GAA 14/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.